The impact of prognosis without treatment on doctors' and patients' resource allocation decisions and its relevance to new drug recommendation processes

British Journal of Clinical Pharmacology

Volumn 65, Issue 2, 2008, Pages 224-229

  Camidge, D Ross ^a,c   Oliver, James J ^a   Skinner, Carolyn ^a   Attwood, Ben ^b   Nussey, Fiona ^a   Jodrell, Duncan ^a   Webb, David J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Cancer; NICE; Prognosis; Resource allocation; Scottish Medicines Consortium

Indexed keywords

ARTICLE; HEALTH ECONOMICS; LIFE EXPECTANCY; LIFESPAN; MEDICAL INFORMATION; PHYSICIAN; PRIORITY JOURNAL; QUALITATIVE RESEARCH; SURVIVAL;

HUMANS; PATIENT SATISFACTION; PHARMACEUTICAL PREPARATIONS; PILOT PROJECTS; PROFESSIONAL PRACTICE; QUESTIONNAIRES; RESOURCE ALLOCATION; TREATMENT OUTCOME;

EID: 38649102467     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2007.02996.x     Document Type: Article

References (12)

1. Taylor RS, Drummond MF, Salkeld G, Sullivan SD. Inclusion of cost-effectiveness in licensing requirements of new drugs: the fourth hurdle. BMJ 2004 329 : 972 5.
2. Cairns J. Providing guidance to the NHS. The Scottish Medicines Consortium and the National Institute for Clinical Excellence compared. Health Policy 2006 76 : 134 43.
3. Camidge R, Walker A, Oliver JJ, Nussey F, Maxwell S, Jodrell D, Webb DJ. Prognosis without treatment as a modifer in health economic assessments. BMJ 2005 330 : 1382 4.
4. Rawlins MD, Culyer AJ. National Institute for Clinical Excellence and its value judgments. BMJ 2004 329 : 224 7.
5. Eghtesad B, Bronsther O, Irish W, Casavilla A, Abu-Elmagd K, van Thiel D, Tzakis A, Fung JF, Starzi TE. Disease gravity and urgency of need as guidelines for liver allocation. Hepatology 1994 20 : 56S 62S.
6. Council on Ethical and Judicial Affairs. American Medical Association. Ethical considerations in the allocation of organs and other scarce medical resources among patients. Arch Intern Med 1995 155 : 29 40.
7. Florin D, Dixon J. Public involvement in health care. BMJ 2004 328 : 159 61.
8. Rawlins MD. Pharmacopolitics and deliberative democracy. Clin Med 2005 5 : 471 5.
9. Weeks JC, Cook EF, OíDay SJ, Peterson LM, Wenger N, Reding D, Harrell FE, Kussin P, Dawson NV, Connors AF, Lynn J, Phillips RS. Relationship between cancer patients' predictions of prognosis and their treatment preferences. JAMA 1998 279 : 1709 14.
10. Neuberger J, Adams D, MacMaster P, Maidment A, Speed M. Assessing priorities for allocation of donor liver grafts: survey of public and clinicians. BMJ 1998 317 : 172 5.
11. Manisty C, Waxman J. Doctors should not discuss resuscitation with terminally ill patients. BMJ 2003 327 : 614 5.
12. Murphy DJ, Burrows D, Santilli S, Kemp AW, Tenner S, Kreling B, Teno J. The influence of the probability of survival on patients' preferences regarding cardiopulmonary resuscitation. N Engl J Med 1994 330 : 545 9.